Intraindividual comparison of two extracorporeal LDL apheresis methods: Lipidfiltration and HELP

International Journal of Artificial Organs

Volumn 25, Issue 12, 2002, Pages 1180-1188

  Julius, Ulrich ^a   Metzler, W ^a   Pietzsch, J ^a   Fassbender T ^b   Klingel, R ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Apheresis Research Institute   (Germany)

Author keywords

Coronary artery disease; Double filtration plasmapheresis; Fibrinogen; Hemorheology; Hypercholesterolemia; LDL Apheresis; Lipidfiltration; Low density lipoprotein cholesterol; Membrane differential filtration

Indexed keywords

CHOLESTEROL; COMPUTER AIDED DESIGN; LIPOPROTEINS; PATIENT TREATMENT; VEGETABLE OILS;

CORONARY ARTERY DISEASE; DOUBLE FILTRATION PLASMAPHERESIS; FIBRINOGEN; HEMORHEOLOGY; HYPERCHOLESTEROLEMIA; LIPIDFILTRATION; LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN APHERESIS; LOW DENSITY LIPOPROTEINS; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; MEMBRANE DIFFERENTIAL FILTRATION;

DISEASES;

CHOLESTEROL; FIBRINOGEN; HEPARIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN; TRIACYLGLYCEROL;

APHERESIS; ARTICLE; BLOOD FILTRATION; BLOOD RHEOLOGY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DIET; DISEASE SEVERITY; EXTRACORPOREAL CIRCULATION; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PLASMA VISCOSITY; PLASMA VOLUME; PLASMAPHERESIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0036959309     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501210     Document Type: Article

References (41)

1. Thompson GR, Miller JP, Breslow JL. Improved survival of patients with homozygous hypercholesterolaemia treated with plasma exchange. Br Med J 1985; 291: 1671.
2. Kroon AA, Aengevaeren WR, Van Der Werf T, et al. LDL apheresis atherosclerosis regression study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis. Circulation 1996; 93: 1826-35.
3. Kopprasch S, Julius U, Gromeier S, Kühne H, Graessler J. Distinct effects of LDL apheresis by hemoperfusion (DALI) and heparin-induced extracorporeal precipitation (HELP) on leukocyte respiratory burst activity of patients with familial hypercholesterolemia. J Clin Apheresis 2000; 15: 249-55.
4. Schuff-Werner P, Gohlke H, Bartmann U. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concentration and the course of coronary heart disease. Eur J Clin Invest 1994; 24: 724-32.
5. Thompson GR, Maher VMG, Matthews S, et al. Familial hypercholesterolaemia regression study: A randomised trial of low-density-lipoprotein apheresis. Lancet 1995; 345: 811-6.
6. Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of Apolipoprotein B. N Engl J Med 1990; 323: 1289-98.
7. Jansen M, Banyai S, Schmaldienst S, et al. Direct adsorption of lipoproteins (DALI) from whole blood: First long-term clinical experience with a new LDL apheresis system for the treatment of familial hypercholesterolemia. Wien Klin Wochenschr 2000; 112/2: 61-9.
8. Julius U, Siegert G, Gromeier S. Intraindividual comparison of the impact of two selective apheresis methods (DALI and HELP) on the coagulation system. Int J Artif Organs 2000; 23: 199-206.
9. Geiss HC, Parhofer KG, Donner MG, Schwandt P. Low density lipoprotein apheresis by membrane differential filtration (cascade filtration). Ther Apheresis 1999; 3: 199-202.
10. Richter WO, Donner MG, Schwandt P. Three low density lipoprotein apheresis techniques in treatment of patients with familial hypercholesterolemia: A long-term evaluation. Ther Apheresis 1999; 3: 203-8.
11. Mabuchi H, Koizumi J, Shimizu M, et al. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group. Am J Cardiol 1998; 82: 1489-95.
12. Julius U, Pietzsch J, Gromeier S, Schorr H, Herrmann W. Homocysteine levels in patients treated with lipid apheresis: Effect of a vitamin therapy. Eur J Clin Invest 2001; 31: 667-71.
13. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97.
14. Drager LJ, Julius U, Kraenzle K, et al. DALI: The first human whole-blood low density lipoprotein and lipoprotein(a) apheresis system in clinical use: Procedure and clinical results. Eur J Clin Invest 1998; 28: 994-1002.
15. Schmaldienst S, Banyai S, Stulnig TM, et al. Prospective randomised cross-over comparison of three LDL apheresis systems in statin pretreated patients with familial hypercholesterolaemia. Atherosclerosis 2000; 151: 493-9.
16. Bosch T, Lennertz A, Kordes B, Samtleben W. Low Density Lipoprotein Hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI Apheresis): Clinical experience from a single center. Ther Apheresis 1999; 3: 209-13.
17. Godehardt E, Messner H, Wallstab UH. Extracorporeal LDL cholesterol elimination by membrane differential filtration. A retrospective analysis of 1702 treatments. In: Gotto AM Jr, Mancini M, Richter WO, Schwandt P, eds. Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease, 4th Int Symp, Munich 1992; Basel, Karger 1993. pp 208-12.
18. Parhofer KG, Geiss HC, Schwandt P. Efficacy of different low-density lipoprotein apheresis methods. Ther Apheresis 2000; 4: 382-5.
19. Seidel D, Armstrong VW, Schuff-Werner P. The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. I. Evaluation of safety and cholesterol-lowering effects during the first 12 months. HELP Study Group. Eur J Clin Invest 1991; 21: 375-83.
20. Jaeger BR. Evidence for maximal treatment of atherosclerosis: Drastic reduction of cholesterol and fibrinogen restores vascular homeostatsis. Ther Apheresis 2001; 5: 207-11.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
22. Nitschke M, Fink K, Pawlow-Handt S, Leeker A, Rob PM, Steinhoff J. Acute renal failure in IgM plasmocytoma with hyperviscosity syndrome. Dtsch Med Wochenschr 1997; 122: 1213-6.
23. Krebs A, Zellner D, Braun N, et al. Multicentre comparison of 5 methods for long-term lipid apheresis between years 1986 to 2001 in 20 patients. Kidney Blood Pressure Res 2001; 24: 213-440.
24. Meier P, Blanc E. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia. Nephrol Dial Transplant 2000; 15: 738-9.
25. Yamane S, Matsugane T, Motohashi K, et al. Double Filtration Plasmapheresis maintains normal adhesion molecule levels. Ther Apheresis 1998; 2: 224-7.
26. Poredos P, Zizek B. Plasma viscosity increase with progression of peripheral arterial atherosclerotic disease. Angiology 1996; 47: 253-9.
27. Otto C, Ritter MM, Richter WO, Minkenberg R, Schwandt P. Hemorrheologic abnormalities in defined primary dyslipoproteinemias with both high and low atherosclerotic risks. Metabolism 2001; 50: 166-70.
28. Koenig W, Sund M, Ernst E. Association between rheology and components of lipoproteins in human blood. Results from the MONICA Project. Circulation 1992; 85: 2197-204.
29. Jung F, Pindur G, Kiesewetter H. Plasma viscosity dependence on proteins and lipoproteins. Clin Hemorheol 1992; 12: 577-71.
30. Koenig W, Ernst E. The possible role of hemorheology in atherogenesis. Atherosclerosis 1992; 94: 93-107.
31. Lowe GDO, Wood DA, Douglas JT. Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 1991; 65: 339-43.
32. Seplowitz AH, Chien S, Smith FR. Effects of lipoproteins on plasma viscosity. Atherosclerosis 1981; 8: 88-95.
33. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL-apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 1997; 95: 76-82.
34. Messner H, Kleophas W, Gries A, et al. Extracorporeal LDL elimination by membrane differential filtration and heparin induced LDL precipitation elevates peripheral oxygen tension. Third International Symposium: Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease. Munich, October, 1990.
35. Tschöpe W, Wallstab UH, Kösters W. Cascade filtration for LDL apheresis: Increase of selectivity. In: Gotto AM Jr. Mancini M. Richter WO. Schwandt P, eds. Treatment of Severe Dyslipoproteinemia in the Prevention of Coronary Heart Disease. Basel: Karger 1993; pp. 213-8.
36. Koenig W, Ditschuneit HHM, Hehr R, Grunewald RW, Ernst E, Hombach V. Blood rheology after LDL apheresis using dextran sulfate cellulose absorption - A case report. Angiology 1992; 43: 606-9.
37. Schamberger BM, Geiss HC, Ritter MM, Schwandt P, Parhofer KG. Influence of LDL apheresis on LDL subtypes in patients with coronary heart disease and severe hyperlipoproteinemia. J Lipid Res 2000; 41: 727-33.
38. Donner MG, Parhofer KG, Richter WO, Schwandt P. Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis. Metabolism 1999; 48: 881-6.
39. Lepage S, Nigon F, Bonnefont-Rousselot D, et al. Oxidizability of atherogenic low-density lipoprotein subspecies in severe familial hypercholesterolemia: Impact of long-term low-density lipoprotein apheresis. J Cardiovasc Pharmacol Ther 2000; 5: 87-103.
40. Pietzsch J, Lattke P, Julius U. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable-isotope studies. Arterioscler Thromb Vasc Biol 2000; 20: E63-7.
41. Pietzsch J, Julius U. Different susceptibility to oxidation of proline and arginine residues of apolipoprotein B-100 among subspecies of low density lipoproteins. FEBS Lett 2001; 23: 123-6.